Medical Countermeasures Mpox Antiviral Clinical Trial Advances as WHO Extends Global EmergencyGlobal Biodefense StaffJuly 17, 2025
Medical Countermeasures Emergent BioSolutions Secures $27 Million in International Orders for Critical Medical CountermeasuresGlobal Biodefense StaffMarch 18, 2025
Industry News Moderna Secures Contract with European Union for COVID-19 VaccinesGlobal Biodefense StaffJanuary 24, 2025
Emergent Biosolutions, Novartis, Texas A&M to Lead New Biodefense Centers Contracts + Grants June 19, 2012 …